Quarterly Targeting

LEVERAGE DATA. TARGET EFFICIENTLY. ACHIEVE SUCCESS.

With the growing channels of promotional tactics and diversified individual features, capturing the right customers as targets becomes crucial to achieve business success.

By leveraging multiple angles and granular levels of data – such as demographic information, writing behaviors, and promotional involvement – we can provide the best approach to meeting the physician within his or her comfort zone. 

As a result, your brand managers will gain a deeper understanding of their brand’s position within the marketplace and will have the tools to formulate strategies utilizing the sales force more effectively to achieve better outcomes and maximize profits.

Related insights

KMK Donates to COVID Relief Effort in India

KMK MAKES DONATION TO AAPI COMMUNITY FUND CHARITY OF GREATER NEW YORK

Making Remote Work in India with Pratik Panchal

KMK Consulting, Inc. Earns 2021 Great Place to Work Certification™

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

KMK Welcomes Oncology Market Research Veteran Lisa Logan

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

KMK Value Based Medicine

Unlock forward looking Insights via Machine Learning

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

KMK’s Split Credit Tool Improves IC Performance

KMK’s Employee Performance Tool Streamlines HQ/Sales Rep Calibration

Field Force Re-Optimization in Anticipation of Loss of Exclusivity (LOE)

IC Plan Design in Defense of Competitive Entry

Sales Force Effectiveness for Top 20 Pharma